Task Order 8 - Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy

任务令 8 - 正在开发的抗癌治疗药物的非临床毒理学研究

• 批准号: 8947142
• 负责人: ALEXANDER LYUBIMOV
• 金额: $ 0.05万
• 依托单位: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8947142
• 关键词: Award; Contracts; Development; Government; Investigation; Malignant Neoplasms; Organ; Pharmaceutical Preparations; Process; Testing; Toxic effect; Toxicology; anti-cancer therapeutic; anticancer activity; cancer therapy; research clinical testing

The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to characterize the target organ toxicities of an investigative agent that might move forward to clinical testing for anticancer activity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer. This Task was terminated for the convenience of the Government.

正在考虑将供试药物开发为抗癌治疗药物。 该任务的目的是表征研究药物的靶器官毒性，从而可能推进抗癌活性的临床试验。 从这项研究中获得的信息被用于确定具有治疗癌症潜力的药物。 这项任务是为了政府的方便而终止的。